Villalpando-Hernández S, Garciá-Bulnes G, Torres-Zamora M, Rojas-Benavides L
Arch Invest Med (Mex). 1981;12(1):59-68.
Two patients with pheochromocytoma predominantly secreting noradrenaline, were studied. Intravenous glucose tolerance tests were performed: in the preoperatory period, under alpha adrenergic blockade with pentolamine and one month after the tumor was removed. Serum glucose and insulin concentrations were determined. Proinsulin was separated from the insulin in Sephadex G-50 fine columns. In the preoperatory study, insulin secretion was less during the first 10 minutes after glucose administration, when comparing to that observed in two other studies. During pentolamine blockade, insulin secretion was at least three times higher than the preoperatory test; however, hypoglycemia was not observed. Proinsulin levels were similar to the observed in a normal individual in the pre and postoperatory test during pentolamine blockade, and were found significantly elevated. It is postulated that hypoglycemia was not produced during the late test because more than 50 per cent of immunoreactivity measured as insulin, corresponded to proinsulin whose biological activity is 10 times less than that of insulin.
对两名主要分泌去甲肾上腺素的嗜铬细胞瘤患者进行了研究。进行了静脉葡萄糖耐量试验:在术前阶段,使用喷妥拉明进行α肾上腺素能阻滞时,以及肿瘤切除后一个月。测定了血清葡萄糖和胰岛素浓度。在Sephadex G - 50细柱中从胰岛素中分离出胰岛素原。在术前研究中,与其他两项研究相比,葡萄糖给药后的前10分钟胰岛素分泌较少。在喷妥拉明阻滞期间,胰岛素分泌至少比术前试验高3倍;然而,未观察到低血糖。在喷妥拉明阻滞期间,术前和术后试验中胰岛素原水平与正常个体中观察到的相似,且发现显著升高。据推测,后期试验中未产生低血糖是因为作为胰岛素测量的免疫反应性超过50%对应于胰岛素原,其生物活性比胰岛素低10倍。